诺沃·诺迪斯克的首席执行官敦促澳大利亚通过更好的标签、健康检查和更快的药物批准,对肥胖症采取行动。 Novo Nordisk's CEO urges Australia to act on obesity with better labels, health checks, and faster drug approvals.

Novo Nordisk主席Mike Doustdar敦促澳大利亚采取全面公共卫生战略, 对抗肥胖危机, 指出1300万成人超重或肥胖。 Mike Doustdar, president of Novo Nordisk, urged Australia to adopt a comprehensive public health strategy to combat its obesity crisis, citing 13 million adults who are overweight or obese. 在国家新闻俱乐部发言时,他呼吁更清晰的食品标签、常规的工作场所健康检查以及更快地批准体重调控药物,将必要的努力与过去在减少吸烟方面取得的成功进行比较。 Speaking at the National Press Club, he called for clearer food labels, routine workplace health checks, and faster approval of weight-management medications, comparing the needed effort to past success in reducing smoking. 他强调了对生产力和保健的压力,强调协调的国家行动对持久变革至关重要。 He emphasized the strain on productivity and healthcare, stressing that coordinated national action is essential for lasting change.